← SynDRA
LY-2608204
SynDRA canonical compound SYN0039555 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GCK |
| Mechanism of action | glucokinase activator |
All known targets
Mechanisms of action (all sources)
- GCK ACTIVATOR
- Hexokinase type IV activator
- glucokinase activator
Drug classes
Cross-references
Synonyms
- Globalagliatin
- LY2608204
- Sy-004
- Glucokinase activator (type 2 diabetes), Eli Lilly
- LY 2608204
- 5A0L003HEY
- (1R,2S)-2-Cyclohexyl-1-(4-cyclopropylsulfonylphenyl)-N-[5-(2-pyrrolidin-1-ylethylsulfanyl)-1,3-thiazol-2-yl]cyclopropane-1-carboxamide
- SY-004
- (1R,2S)-2-Cyclohexyl-1-(4-(cyclopropylsulfonyl)phenyl)-N-(5-((2-(1-pyrrolidinyl)ethyl)thio)-2-thiazolyl)cyclopropanecarboxamide
- (1R,2S)-2-cyclohexyl-1-[4-(cyclopropanesulfonyl)phenyl]-N-(5-{[2-(pyrrolidin-1-yl)ethyl]sulfanyl}-1,3-thiazol-2-yl)cyclopropane-1-carboxamide
- UNII-5A0L003HEY
- SCHEMBL1344892
- GLOBALAGLIATIN [WHO-DD]
- CHEMBL4297399
- EX-A158
- MFCD21609257
- s2155
- ZINC70471849
- AKOS027314130
- BCP9000874
- CCG-270044
- CS-1281
- DB12284
- AC-35321
- AS-75181
- HY-13529
- J-690089
- BRD-K12068470-001-04-1
- Q27261730
- (1r,2s)-2-cyclohexyl-1-(4-cyclopropanesulfonyl-phenyl)-cyclopropanecarboxylic acid [5-(2-pyrrolidin-1-yl-ethylsulfanyl)-thiazol-2-yl]-amide
- Cyclopropanecarboxamide, 2-cyclohexyl-1-[4-(cyclopropylsulfonyl)phenyl]-N-[5-[[2-(1-pyrrolidinyl)ethyl]thio]-2-thiazolyl]-, (1R,2S)-
- HMS3655J04
- BCP02549
- SCHEMBL12131683
- NCGC00389788-02
- DA-33423
- LS-15245
- FT-0773586
Look up LY-2608204 in the interactive SynDRA portal →